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tively, in these rats at 24 hours, without significant changes inUp-regulation of parathyroid hormone-related protein in folic
either renal function or calcemia. On the other hand, this pep-acid-induced acute renal failure.
tide failed to modify the increase (2-fold over control) in ACEBackground. Parathyroid hormone (PTH)-related protein
mRNA, associated with a prominent Ang II staining into tubu-(PTHrP) is present in many normal tissues, including the kid-
lar cell nuclei, in the kidney of folic acid-treated rats at thisney. Current evidence supports that PTHrP is involved in renal
time period. The addition of 10 mmol/L folic acid to NRK 52Epathophysiology, although its role on the mechanisms of renal
cells caused a twofold increase in PTHrP mRNA at six hours,damage and/or repair is unclear. Our present study examined
without significant changes in the PTH/PTHrP receptor mRNA.the changes in PTHrP and the PTH/PTHrP receptor (type 1)
The presence of two anti-PTHrP antibodies, with or withoutin folic acid-induced acute renal failure in rats. The possible role
folic acid, in the cell-conditioned medium decreased (40%, Pof PTHrP on the process of renal regeneration following folic
acid administration, and potential interaction between angio- 0.01) cell growth.
tensin II (Ang II) and endothelin-1, and PTHrP, were exam- Conclusions. Renal PTHrP was rapidly and transiently in-
ined in this animal model. creased in rats with folic acid-induced acute renal failure, fea-
Methods. PTHrP, PTH/PTHrP receptor, ACE, and prepro- turing as an early response gene. In addition, changes in ACE
endothelin-1 (preproET-1) mRNA levels in the rat kidney were and Ang II expression were also found in these animals. PTHrP
analyzed by reverse transcription-polymerase chain reaction induces a mitogenic response in folic acid-damaged renal tubu-
(RT-PCR) and/or RNase protection assay. Immunohistochem- lar cells both in vivo and in vitro. Our results support the notion
istry also was performed for PTHrP, the PTH/PTHrP receptor, that PTHrP up-regulation participates in the regenerative pro-
and Ang II in the renal tissue of folic acid-injected rats. The cess in this model of acute renal failure and is a common event
role of PTHrP on tubular cell proliferation following folic acid associated with the mechanisms of renal injury and repair.
injury was investigated in vitro in rat renal epithelial cells (NRK
52E). PTHrP secretion in the medium conditioned by these
cells was measured by an immunoradiometric assay specific
Parathyroid hormone (PTH)-related protein (PTHrP)for the 1-36 sequence.
Results. Using RT-PCR, PTHrP mRNA was rapidly (1 hour) is present in the vast majority of normal fetal and adult
and maximally increased (3-fold) in the rat kidney after folic tissues, including the kidney, and it appears to act as an
acid, decreasing after six hours. At 72 hours, renal function was autocrine/paracrine factor [1, 2]. In adults, PTHrP is
maximally decreased in these rats, associated with an increased
widely present along the nephron and in the intrarenalPTHrP immunostaining in both renal tubules and glomeruli. In
arterial tree, and current evidence points to an emergingcontrast, the PTH/PTHrP receptor mRNA (RNase protection
assay) decreased shortly after folic acid administration. More- role of PTHrP in renal physiology [1, 3, 4]. An increasing
over, PTH/PTHrP receptor immunostaining dramatically de- number of studies support the notion that PTHrP, acting
creased in renal tubular cell membranes after folic acid. A through its N-terminal region homologous to PTH, issingle subcutaneous administration of PTHrP (1-36), 3 or 50
involved in the control of vascular tone [5, 6]. In thisg/kg body weight, shortly after folic acid injection increased
regard, PTHrP (1-34) induces vasorelaxation in the pre-the number of tubular cells staining for proliferating cell nu-
clear antigen by 30% (P  0.05) or 50% (P  0.01), respec- constricted isolated rabbit kidney [3]. Moreover, this
peptide increases glomerular filtration rate and renal
blood flow when infused into the renal artery of anesthe-Key words: kidney regeneration, angiotensin converting enzyme, endo-
thelin-1, angiotensin II, mitogenesis, renal repair, tissue repair. tized rats [7]. However, the true role of local PTHrP in
the kidney as a regulator of the renal vascular tone re-Received for publication August 23, 2000
mains unclear, since this peptide also increases renaland in revised form March 15, 2001
Accepted for publication March 29, 2001 renin secretion [8]. Recent studies have demonstrated
that PTHrP might directly modulate glomerular function 2001 by the International Society of Nephrology
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by interacting with the contracting-relaxing capabilities removed. At 1.5 hours following folic acid administra-
tion, other groups of six animals each were injected sub-of glomerular mesangial cells [9, 10].
Parathyroid hormone-related protein also exhibits cutaneously with PTHrP (1-36) (kindly donated by Dr.
A.F. Stewart, Department of Endocrinology, Universitygrowth-regulatory properties in renal tubular and mesan-
gial cells [4, 10–13]. Renal PTHrP expression is rapidly of Pittsburgh, PA, USA), at 0.3, 3, and 50 g/kg, respec-
tively, in saline with 0.1% bovine serum albumin (BSA).and transiently up-regulated during the recovery period
after ischemic injury in vivo and in vitro and in cyclospo- These doses were selected because they have shown to
elicit various renal and bone effects in humans and ratsrine-induced chronic nephrotoxicity [4, 13, 14]. More-
over, we recently found a sequential increase of PTHrP, [20, 21]. On the other hand, acute or chronic administra-
tion of this peptide and other related peptides in thisassociated with a decreased PTH/PTHrP (so called type
1) receptor, in the renal cortex of rats during the develop- dose range into normal subjects failed to affect either
renal function or calcemia [20, 21]. At 24 hours afterment of proteinuria after albumin overloading [15].
These findings suggest that PTHrP overexpression might folic acid administration, these rats were killed under
ether anesthesia, and kidneys were collected. One kidneybe related to the mechanisms associated with renal injury
and also with the progression of renal damage. from each animal in all groups was fixed in 4% buffered
p-formaldehyde for light microscopy examination andIn the present study, considering the PTHrP features
in glomerular function and tubular growth described pre- immunohistochemistry. The other kidney was snap-fro-
zen in liquid nitrogen and stored at70C for subsequentviously in this article, we hypothesized that this protein
might play a role in the injured kidney and in the subse- RNA extraction. Some kidney tissue samples were
freeze-dried, and then lyophilized samples were dis-quent renal regenerative process. To assess this hypothe-
sis, the renal expression of PTHrP and the PTH/PTHrP solved in 0.1 N NaOH. Protein was determined in tissue
extracts by the Bradford’s method, using BSA as thereceptor were examined in rats with acute renal failure
induced by folic acid. A dramatic renal tubular hyperpla- standard [22].
sia occurs in this animal model, but in contrast to other
Blood chemistryexperimental models of acute renal failure, kidney lesions
following folic acid injection are only moderate [16–18]. Blood was taken by cardiac puncture under ether anes-
thesia after an overnight fast. Plasma creatinine andSince the mitogenic effects of PTHrP on renal cells had
only been characterized in vitro, we investigated whether blood urea nitrogen (BUN) were determined by auto-
analyzer (Hitachi Chemistry System; Boehringer Mann-exogenous administration of PTHrP would increase re-
nal epithelial regeneration in this in vivo model. In addition, heim, Mannheim, Germany).
the changes of angiotensin-converting enzyme (ACE) and
Histologic studies and immunohistochemistrypreproendothelin-1 (preproET-1), whose expression in-
crease in parallel to PTHrP in the renal cortex of rats with Fixed renal tissue sections were dehydrated by graded
ethanols and xylene and then embedded in paraffin. Par-intense proteinuria [15], as well as those of angiotensin II
(Ang II) were evaluated in the kidney of rats after folic affin-embedded tissue sections (4 m) were mounted on
3-aminopropyltriethoxy silane-treated slides for histo-acid injury. In addition, the putative direct effects of folic
acid on PTHrP production in rat kidney epithelial cells logic evaluation or immunohistochemistry. Kidney sec-
tions were stained with hematoxylin and eosin.in vitro and its role on cell growth were assessed. Our
studies provide further insights into the emerging role Parathyroid hormone-related protein immunostaining
was carried out with affinity purified anti-PTHrP antibodyof PTHrP as a renal regulating factor [19], supporting its
participation in the regenerative process in the damaged Ab-2 (Oncogene, Uniondale, NY, USA), recognizing
the sequence 34 to 53 of human and rat PTHrP [14, 15].kidney.
The PTH/PTHrP receptor staining was performed with
an affinity-purified antibody against the extracellular
METHODS
domain of this receptor in the rat (Ab VII; Babco, Rich-
Animal model mond, CA, USA) [23]. For Ang II staining, a rabbit anti-
serum to Ang II (Peninsula Laboratories, San Carlos, CA,Male Wistar rats (250 g body weight) were fed stan-
dard rat chow ad libitum and were given free access to USA) was used. Proliferative activity was evaluated with a
monoclonal antiproliferating cell nuclear antigen (PCNA;water. One group of rats received a single intraperitoneal
injection of folic acid (Sigma, St. Louis, MO, USA), Clone PC10; Dako, Glostrup, Denmark). Immunostain-
ing was performed as described in detail [15, 23]. Briefly,250 mg/kg in 150 mmol/L sodium bicarbonate (vehicle).
Control animals received the same volume of vehicle tissue sections were incubated with 1.5% normal goat
serum in phosphate-buffered saline (PBS) for 30 minutesalone. At different time periods up to 10 days after folic
acid injection, four to eight animals from each group and then with 4 g/mL of Ab-2 antibody, 5 g/mL of
Ab-VII antibody, 400-fold dilution of anti-Ang II anti-were sacrificed under ether anesthesia, and kidneys were
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In all cases, morphologic and immunologic evaluations
of tissue samples were performed by two independent
observers in a blinded fashion. PTHrP immunostaining
was scored at glomerular and tubular level and graded as
follows: 0, negative staining; 1, mild staining; 2, moderate
staining; and 3, intense staining. Tubular staining for
PCNA was evaluated in three 100 microscopic fields
by counting the number of stained cell nuclei per field
and then calculating the mean from each rat. In addition,
the number of stained cells per 20 glomeruli without
selection was also counted for each rat [25]. The final
score was always the mean of the two evaluations.
Cell culture
Rat kidney cells NRK 52E (ATCC CRL 1571), dis-
playing a tubuloepithelial phenotype [26, 27], were grown
in Dulbecco’s modified essential medium (DMEM) with
5% fetal bovine serum (FBS; BioWhittaker, Verviers,
Belgium), 100 U/mL penicillin, and 100 g/mL strepto-
mycin, in 5% CO2 at 37C. Cells were serum-depleted
for 24 hours before addition of 10 mmol/L folic acid
dissolved in 300 mmol/L NaHCO3. This addition did not
change the medium pH. In some experiments, subcon-
fluent cells were incubated for 48 hours in serum-free
medium with folic acid in the presence or absence of
affinity-purified anti-PTHrP antiserum C7 or C13, recog-
nizing either the C- or N-terminal region of PTHrP,
respectively [28]. Then cells were trypsinized and resus-
pended in trypan blue. Viable cells were counted in a
hemocytometer.Fig. 1. Time-course of changes in plasma creatinine (A) and blood
urea nitrogen (BUN; B) in rats with folic acid-induced acute renal
RNA extractionfailure. Measurements were from blood samples obtained in rats after
overnight fast, using standard methods. Points are mean  SEM of Total RNA was isolated from either rat kidney homog-eight animals at each time period. All values were significantly different
enates obtained with a glass-Teflon homogenizer, or(P  0.05 or less) from the corresponding values in vehicle-injected
(control) rats () at each time period studied within one hour and six FBS-depleted NRK 52E cells, using TriReagent (1 mL
days. *P  0.05; aP  0.01, compared with the corresponding values in per g wet tissue or 106 cells, respectively; Molecular Re-
folic acid-treated rats () at six hours. **P  0.05 compared with 240
search Center, Inc., Cincinnati, OH, USA), according tohours.
the manufacturer’s instructions.
Reverse transcription-polymerase chain reaction
serum, or 150-fold dilution of PCNA antibody for either To assess changes in mRNA levels by semiquantitative
two hours (Ab-2 and Ab-VII) or 30 minutes (Ang II reverse transcription-polymerase chain reaction (RT-
and PCNA antibodies). Sections were subsequently incu- PCR), total RNA from either rat kidney (5 ng for the
bated with either goat anti-rabbit (Ab-2 and Ab-VII) or PTH/PTHrP receptor; 10 ng for c-fos; and 100 ng for
anti-mouse IgG (PCNA antibody) and the avidin-biotin- the other genes studied), or NRK 52E (100 ng for the
peroxidase complex (Vector, Burlingame, CA, USA). PTH/PTHrP receptor and 20 ng for PTHrP) was reverse
Following incubation with the Ang II antiserum, the sec- transcribed, and resulting cDNA was amplified, using
tions were incubated with a polymer-peroxidase complex a commercial kit (Access RT-PCR System; Promega,
(EnvisionSystem; Dako). 3,3-Diaminobenzidine was Madison, WI, USA), with specific primers for the rat
used as the chromogen. Some tissue sections were treated PTH/PTHrP receptor [23], PTHrP, ACE, preproET-1
either with nonimmunogenic IgG or without the primary [15], and c-fos [5-GGGAATTCGGAGAATCCGAA
antibody, as negative controls. Staining of the capillary GGGAAAGG-3 (sense), and 5-CCGGATCCGTGA
network and peritubular connective tissue was consid- AGGCCTCCTCAGACTC-3 (antisense)]. These prim-
ered as a positive internal control for Ang II [24]. The ers yield PCR amplification products of 266 bp (PTHrP),
tissue sections were counterstained with Carazzi’s hema- 495 bp (PTH/PTHrP receptor), 317 bp (ACE), 409 bp
(preproET-1), and 316 bp (c-fos). The housekeeping gene,toxylin.
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Fig. 2. Histologic examination of a rat kidney section at six hours after
folic acid injection. Folic acid deposit (yellow-brownish crystals) is shown
in the glomerular mesangium and the glomerular capillary tufts. Tubular
dilation was evident, as well as edema and yellowish casts in the tubular
epithelium (magnification 200). Reproduction of this figure in color
was supported by the Spanish Ministry of Science and Technology.
Fig. 4. Immunostaining for parathyroid hor-
mone-related protein (PTHrP) and the PTH/
PTHrP receptor in the kidney of folic acid-in-
jured rats. Kidney sections of representative
folic acid-treated (A and C) or -untreated (B
and D) rats, showing immunolocalization of
PTHrP by Ab-2 antibody (A and B), and of
the PTH/PTHrP receptor by using Ab-VII
antibody (C and D). A dramatic increase in
PTHrP positivity was observed in both proxi-
mal and distal tubules in folic acid-treated rats.
In contrast, PTH/PTHrP receptor staining,
which was present in the basolateral mem-
branes of the proximal tubules in the kidney
cortex of control rats, almost disappeared at
72 hours after folic acid injection. Negative
control without primary antibody (E). Magni-
fications 100 (A–C and E) and 500 (D).
Reproduction of this figure in color was sup-
ported by the Spanish Ministry of Science and
Technology.
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Fig. 3. Parathyroid hormone-related protein (PTHrP) and c-fos mRNA
in the rat kidney following folic acid injury. Total RNA was isolated
from the kidney of folic acid-treated or -untreated rats at different time
periods. (A) PTHrP and GAPDH mRNA, a constitutive control, and
(B) c-fos mRNA were evaluated by RT-PCR. (A) Densitometric analy-
sis corresponding to changes in PTHrP mRNA levels, corrected to those
of GAPDH mRNA, induced by folic acid. Results are mean  SEM
corresponding to two different total RNA pools, each obtained from
five different animals, and three individual animals per group. *P 
0.01 compared with control (C; 100%).
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), RNase protection assay
was amplified using specific primers as a constitutive RNase protection analysis was performed as described
control [15]. The reaction mixture (10 L), with 0.5 Ci by Thiede et al [29], using 40 g of total RNA and a
[	 32P]dCTP (3000 Ci/mmol; NEN Life Science Products, 481 bp antisense cRNA probe, corresponding to a 151
Zaventem, Belgium), was incubated for 45 minutes at to 631 bp fragment of the coding region of the rat PTH/
48C and two minutes at 95C, followed by 30 cycles of PTHrP receptor gene, cloned into the PCR-II plasmid
one minute at 95C, one minute at 60C, and two minutes
(Invitrogen, Groningen, The Netherlands). An antisense
at 68C, with a final extension of seven minutes at 68C.
cRNA probe corresponding to a 115 bp fragment of thePreliminary experiments established that these conditions
human 28S rRNA gene (Ambion, Austin, TX, USA) wasprovided a linear cDNA amplification in each case.
used as an internal standard. Antisense cRNA probes32P-labeled PCR products were separated on 4% poly-
were 32P-labeled and hybridized to total RNA from eachacrylamide gels, which were dried and exposed to auto-
sample in 80% formamide, 40 mmol/L piperazine-N,N-radiographic film. Values obtained after densitometric
bis(2-ethanosulfonic acid), pH 6.7, and 400 mmol/L NaCl,scanning (ImageQuant; Molecular Dynamics, Sunny-
at 55C overnight. Samples were sequentially treatedvale, CA, USA) of the different PCR products were
with RNase A (40 g/mL), RNase T1 (2 g/mL), andnormalized against those of the corresponding GAPDH
product. proteinase K (60 g/mL). RNA hybrids were then phe-
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The cell-conditioned medium was freeze dried and then
tenfold concentrated in assay buffer before assay.
Statistical analysis
Results are expressed as mean  SEM throughout
the text. Statistical analysis was performed by either the
Kruskal-Wallis test or Mann-Whitney test, when appro-
priate. P  0.05 was considered significant.
RESULTS
Changes in renal function after folic acid injection
The mean values for plasma creatinine and BUN in
folic acid-injected animals were significantly increased
at one hour, peaked at 24 hours, and plateaued up to
day 6, decreasing thereafter, as compared with the corre-
sponding mean values in vehicle-treated animals (Fig.
1). At day 10 after folic acid administration, rat plasma
creatinine and BUN levels reached the corresponding
values in the control rats (Fig. 1).
Changes in renal morphology after folic acid-induced
acute injury
Histological examination of rat kidney tissue samples
indicates that at one hour after folic acid injection, the
renal cortex showed tubular distention, and folic acid
precipitation presented as yellowish casts in the renal
medulla. At six hours following folic acid administration,
tubular dilation was a consistent finding, and edema and
yellowish casts also were observed in the proximal tu-
bules. At this time period, the tubular epithelium began
to become thinner, showing cells coming off from the
Fig. 5. PTH/PTHrP receptor in the rat kidney following folic acid basal membrane into the lumen, and even some tubules
injury. Total RNA was isolated from the kidney of folic acid-treated were fragmented (Fig. 2). In addition, occasionally at
or -untreated rats at different time periods. (A) Autoradiogram showing
this time period, folic acid deposition was evident in thethe analysis of the PTH/PTHrP receptor mRNA, and 28S mRNA as a
constitutive control, using RNase protection assay. (B) Densitometric glomerular mesangium. Moreover, yellowish casts were
analysis of changes in the PTH/PTHrP receptor mRNA levels, corrected present in both the urinary space and the glomerular
to those of 28S mRNA, induced by folic acid. Results are mean  SEM
capillary tufts, which were clearly dilated (Fig. 2). At 24corresponding to three different total RNA pools each obtained from
five different animals per group. *P  0.05; ** P  0.01 compared with hours, folic acid deposits were only present in tubules
control (100%); aP  0.02 compared with the value at six hours. FA, of the renal medulla, while no such deposits could be
folic acid; C, control.
observed at 48 hours. Ten days after folic acid-induced
injury, some tissue disorganization, including edema and
tubular dilation, was still evident.nol/chloroform extracted, followed by ethanol precipita-
tion. Protected fragments were fractionated on 6.5%
Increase of renal PTHrP expression following folicpolyacrilamide/7 mol/L urea sequencing gels and ana-
acid injurylyzed by autoradiography. Values obtained after densito-
Using semiquantitative RT-PCR, we found that PTHrPmetric scanning of the PTH/PTHrP receptor bands were
mRNA in the rat kidney was rapidly (1 hour) and maxi-normalized against those of the corresponding 28S band.
mally increased after folic acid injection, being threefold
PTHrP assay over that of vehicle-treated rats, decreasing after six hours
(Fig. 3A). This response pattern was similar to that ob-Parathyroid hormone-related protein in rat plasma
served with the protooncogene c-fos mRNA in theseand NRK 52E cell-conditioned medium was measured by
animals (Fig. 3B).an immunoradiometric assay, using affinity-purified rabbit
Furthermore, immunohistochemistry was performedantisera against rat and human PTHrP (1-36) as signal
and capture antibodies, with a sensitivity of 1 pmol/L [30]. to assess the sites of PTHrP changes in the rat kidney.
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Fig. 6. Renal tubular cell proliferation fol-
lowing folic acid injury. Tubular cell prolifera-
tion in the kidney of folic acid-treated and
-untreated rats at different time periods was
evaluated by immunohistochemistry using a
PCNA antibody. Staining in tubule cell nuclei
in either a folic acid-treated (A) or a vehicle-
treated rat (B) at 24 hours. Magnification100.
At 72 hours after folic acid treatment, when renal function in the rat kidney after folic acid administration, according
to the RNase protection assay (Fig. 5) and RT-PCRwas maximally decreased, an increased PTHrP staining
in the renal cortex was found (Fig. 4 A, B). The corre- (data not shown). Furthermore, PTH/PTHrP receptor
immunostaining, which was present in both basolateralsponding score values in the renal tubules and glomeruli
were as follows: 2.5  0.2 and 1.7  0.1 compared with and luminal membranes in the renal cortical tubules of
control rats, dramatically decreased at 72 hours followingcontrol rats (1.5  0.1 and 1.0  0.1, respectively, P 

0.03); meanwhile, at day 10, when renal function had folic acid treatment (Fig. 4 C, D).
normalized, these score values were not different from
PTHrP increases renal tubular cell proliferationthose in the controls (1.9 0.2 and 0.9 0.3, respectively,
following folic acid injuryN 
 5).
Folic acid was found to induce an increase in the num-
The renal PTH/PTHrP receptor decreases after folic ber of proliferating renal tubular cells, which was dra-
acid injury matic between 24 and 72 hours and no longer present
at 10 days following folic acid injection (Fig. 6). ThisThe PTH/PTHrP receptor mRNA was found to de-
crease in association with the decrease in renal function tubular cell hyperplasia was not accompanied by an in-
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Fig. 6 (Continued). (C) Score values are
mean  SEM of four to six animals at each
time period. *P  0.025 compared with value
at six hours. aP  0.05 compared with value
at 240 hours.
Table 1. Plasma immunoreactive PTHrP (1-36) at 30 minutes after with 50 g/kg PTHrP (1-36), respectively (N 
 5). This
subcutaneous injection of PTHrP (1-36)
effect of exogenously administered PTHrP (1-36) on tu-
g/kg Concentration bular proliferation was associated with a significant de-
Condition body weight pmol/L crease in PTHrP mRNA (Fig. 7B). On the other hand,
FA 1–2 this mitogenic effect of PTHrP (1-36) was not associated
FA PTHrP 50 2710 with significant changes in either plasma calcium (dataFA PTHrP 3 309
not shown) or renal function (Table 2). Moreover, noFA PTHrP 0.3 102
significant correlation was found between tubular cellData are mean  SEM of 6–8 rats. Abbreviations are: PTHrP, parathyroid
hormone-related protein; FA, folic acid. proliferation and either plasma creatinine or BUN at
24 hours following folic acid injection and PTHrP (1-36)
(3 or 50 g/kg) treatment [r 
 0.30, P 
 0.229 (plasma
creased renal hypertrophy. Thus, the protein content of creatinine) or r 
 0.23, P 
 0.328 (BUN), N 
 20].
the rat kidney at 24 and 72 hours after folic acid treat-
ment was (g/g), 0.6  0.1, and 0.7  0.1 compared with Renal expression of ACE and preproET-1 in rats with
0.5  0.1 (control, N 
 5), respectively. folic acid injury
To investigate the relationship between the increase Angiotensin-converting enzyme mRNA increased two-
of PTHrP in the rat kidney and renal hyperplasia induced fold in the kidney of folic acid-injected rats at 24 hours,
by folic acid, PTHrP (1-36) was administered into rats when renal function was maximally decreased, compared
shortly after folic acid injection. This peptide, at the doses with vehicle-treated controls (Fig. 8). Exogenous admin-
used, was rapidly absorbed and present in rat plasma istration of PTHrP (1-36), in contrast to its tubular prolif-
after its subcutaneous injection (Table 1), consistent with erative effect, was not shown to affect this increased
previous findings in humans [20]. A single administration ACE mRNA significantly within the same time frame
of either 3 or 50 g/kg body weight, but not 0.3 g/kg, in these animals (Fig. 8). On the other hand, preproET-1
of PTHrP (1-36) into these animals significantly increased mRNA did not change after either folic acid or PTHrP
the number of PCNA-positive tubular cells at 24 hours (1-36) treatments in these rats (Fig. 8A).
after folic acid injection (Fig. 7A). In contrast, at this time
Ang II immunoreactivity in the kidney ofperiod, PTHrP (1-36) administration did not significantly
folic acid-injured ratsincrease PCNA immunostaining in the glomerulus in
these animals: 0.8  0.4 and 0.6  0.3 positive cells per Ang II immunoreactivity was also localized in the rat
kidney before and after folic acid injection. In vehicle-glomerulus in folic acid-injected rats, untreated or treated
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Fig. 7. Effect of PTHrP(1-36) administration
on tubular cell proliferation and PTHrP mRNA
in the rat kidney after folic acid injury. Differ-
ent doses of PTHrP (1-36) were administered
subcutaneously into rats 1.5 hours after folic
acid or vehicle injection. Twenty-four hours
later, tubular cell proliferation was assessed
by PCNA staining, and PTHrP mRNA was
analyzed by RT-PCR. (A) Staining score val-
ues are mean  SEM of six rats. *P  0.01;
aP 0.05 compared with FA alone. bP 0.05;
**P 0.05, compared with values correspond-
ing to FA and either PTHrP (1-36) at 0.3 or
50 g/kg body wt, respectively. (B) Represen-
tative results of two different pools of total
RNA from three different animals in each case.
GAPDH mRNA is shown as a constitutive
control. FA, folic acid.
injected animals, Ang II immunostaining was found in
the cytoplasm of tubular cells, which was prominent in
the brush border (Fig. 9B). At 24 hours following folicTable 2. Plasma creatinine and blood urea nitrogen (BUN) in
acid injection, intense Ang II positivity was mainly local-vehicle (control)- and folic acid (FA)-treated rats, with or without
parathyroid hormone-related protein (PTHrP) (1-36), at 24 hours ized into tubular cell nuclei (Fig. 9C).
Creatinine BUN
g/kg Role of PTHrP on folic acid-induced injury in renal
Condition body wt mg/dL epithelial cells
Control 0.50.03 151
To explore the mitogenic effect of PTHrP on renalFA 2.00.2a 809a
tubular cells in folic acid-treated rats further, we used theControl  PTHrP 50 0.50.01 131
FA PTHrP 50 2.50.3b 967b rat renal epithelial cells, NRK 52E. These cells express
FA PTHrP 3 2.40.4b 1118b PTHrP and the PTH/PTHrP receptor (Fig. 10A). Treat-FA PTHrP 0.3 1.70.3b 10515b
ment of these cells with 10 mmol/L folic acid stimulated
Data represent mean  SEM of 6 animals per group.
PTHrP mRNA expression, representing twofold overa P  0.01, relative to control value
b P  0.01, relative to control  PTHrP value that of vehicle-treated cells at six hours (Fig. 10). In
addition, PTHrP immunoreactivity in the cell-condi-
tioned medium in the presence of folic acid for 24 hours
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Fig. 8. Effect of folic acid on angiotensin-converting enzyme (ACE)
and preproendothelin-1 (preproET-1) mRNA in the rat kidney. Para-
thyroid hormone-related protein (PTHrP) (1-36) (3 g/kg body weight)
was administered into some rats, as described in the text. Total RNA
was isolated from the kidney of folic acid (FA)-treated or -untreated
rats at 24 hours. (A) Autoradiograms showing each gene mRNA analysis
using RT-PCR. (B) Densitometric analysis of the changes in ACE
mRNA levels, corrected to those of GAPDH mRNA. Results are
mean  SEM corresponding to three different total RNA pools each
obtained from three to five different animals per group. *P  0.05
compared with control (100%).
was 0.9 0.2 fmol/mg cell protein, while it was undetect- through its potent vasodilatory effect [3, 7, 9, 10]. In addi-
able in vehicle-treated medium for the same time period. tion, in vitro studies have demonstrated that this factor is
On the other hand, 10 mmol/L folic acid failed to affect mitogenic for various renal cells, including mesangial
the PTH/PTHrP receptor mRNA within the same time cells, distal tubule-like cells, and proximal tubule cells
frame (Fig. 10A). [4, 10–13]. Renal PTHrP expression increases in vivo in
The presence of two different anti-PTHrP antibodies rats during the recovery phase after ischemic injury and
in the cell-conditioned medium significantly reduced the also in rats with chronic renal failure [4, 14, 15].
cell number after 48 hours (Fig. 11). Moreover, the addition The recovery of renal function after nephrotoxic or
of 10 mmol/L folic acid to NRK 52E cells for the same ischemic acute renal failure requires the repair of the
time period induced a decrease in the cell number, which damaged renal tubular epithelium, which is apparently
was significantly lower in the presence of the anti-PTHrP dependent on the local production of several growth
antibodies but not nonimmune rabbit IgG (Fig. 11). factors and cytokines [33, 34]. Recent in vitro findings
suggest an emerging role for PTHrP in the process of
renal regeneration following renal ischemia [13]. TheDISCUSSION
present study evaluated the possible involvement ofParathyroid hormone-related protein and/or the PTH/
PTHrP in the intense renal tubular hyperplasia followingPTHrP receptor are present in the adult kidney in vari-
acute renal injury induced by folic acid [16–18]. PTHrPous nephron sites, including proximal, distal, and collect-
was rapidly and transiently increased in the kidney ofing tubules, the glomerular podocytes, and also in the
folic acid-injected rats. Moreover, PTHrP immunostain-intrarenal arterial tree and the macula densa [1, 3, 4, 31,
ing increased in both tubules and glomeruli, associated32]. In the kidney, PTHrP appears to affect glomerular
with the maximal decrease of renal function followingfunction by both its direct interaction with the contracting-
relaxing capabilities of glomerular mesangial cells and folic acid injection. In the renal ischemia model, using
Santos et al: PTHrP and folic acid in ARF992
[4]. These different results regarding glomerular PTHrP
staining in both models of acute renal injury might be
explained by differences in either antibody affinities or
the immunohistochemical technique used in both stud-
ies. However, these findings also suggest that different
underlying mechanisms mediate the glomerular response
in these two animal models of acute renal damage. In
this regard, putative glomerular damage associated with
the observed folic acid deposits in the glomerulus could
be responsible for the increased glomerular PTHrP stain-
ing in rats with folic acid injury. Our findings indicate
that these deposits, which had previously been reported
to occur only in the renal tubules, can also occur in the
glomerulus. Furthermore, in this segment, some dilated
capillaries were observed near the yellowish folic acid
deposits in the mesangium, suggesting folic acid deposi-
tion in the capillary lumen, which would affect renal
microcirculation.
The present study found, to our knowledge for the
first time, an up-regulation of ACE mRNA in the kidney
of folic acid-treated rats. Interestingly, intense Ang II
immunostaining was localized mainly in the nuclei of
renal tubular cells in these animals. In this regard, ACE
and/or Ang II immunoreactivity previously have been
found in the cell nucleus in several tissues, including the
kidney [35–37]. In one of these studies, an Ang II-
induced nuclear targeting of the Ang II subtype 1 (AT1)
receptor has been demonstrated in rat neurons, which
possibly is related to the chronic neuromodulatory ef-
fects of Ang II [37]. Whether such a mechanism has a
putative role in the folic acid-injured kidney is presently
unknown.
We found that the PTH/PTHrP receptor, both its
mRNA expression and immunostaining, dramatically
decreased in the rat kidney associated with folic acid-
induced renal injury. The changes in PTHrP and the
PTH/PTHrP receptor as found herein are consistent with,
but opposite to, those reported for other growth factors
and their receptors, such as for epidermal growth factor
and hepatocyte growth factor (HGF), which have a role
in the renal regenerative process in this model of acute
Fig. 9. Immunostaining for angiotensin II (Ang II) in the kidney of
renal failure [33, 34]. Down-regulation of the PTH/PTHrPfolic acid (FA)-injured rats. Kidney sections of representative FA-
treated (C) or -untreated (A and B) rats, showing Ang II immunolocali- receptor, as found in the present study, has been reported
zation (B and C). Angiotensin II staining was mainly present in the to occur in other models of renal injury associated with
luminal membranes of cortical tubules in the kidney cortex of control
increased renal PTHrP [4, 15]. In this regard, PTH treat-rats (B). In contrast, Ang II positivity was predominantly associated
with renal tubule cell nuclei in the kidney of FA-treated rats (C). Similar ment has been shown to decrease PTH binding and PTH-
findings were observed in at least four different animals per group. stimulated cAMP accumulation in renal cells both in
Negative control without primary antibody (A). Magnifications 200
vitro and in vivo [38–40]. Moreover, the increase in renal(A) and 100 (B and C).
Ang II in folic acid-injected animals also could down-
regulate the PTH/PTHrP receptor, as occurs in vascular
smooth muscle cells [41]. Indeed, there is evidence sug-
an anti-PTHrP antibody with a similar specificity to that gesting the existence of PTHrP receptors other than the
of the antibody used herein, a dramatic increase in tubu- PTH/PTHrP receptor in different tissues and in the kid-
lar, but not in glomerular, PTHrP staining was found in ney [1, 10, 28, 42]. On the other hand, PTHrP and/or
the PTH/PTHrP receptor can be internalized into thethe rat kidney during the recovery phase after ischemia
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Fig. 11. Effect of folic acid and different anti-PTHrP antibodies on
NRK 52E cell number. Subconfluent cells were incubated for 48 hours
in serum-depleted medium with or without 10 mmol/L folic acid in the
presence or absence of either anti-PTHrP antiserum C7 or C13 or
nonimmunogenic rabbit IgG at 5 g/mL. Then, viable cells were counted
in a hemocytometer. Values are mean  SEM of results in three to six
different cell cultures in triplicate. *P  0.01 compared with antibody-
untreated (basal) control value; **P  0.01 compared with the folic
acid-treated basal value.
nucleus in several cell types, including renal cells [43–45].
Clarification of the possible relevance of these mecha-
nisms for the renal effects of PTHrP awaits further
studies.
The PTHrP mRNA up-regulation in the kidney of folic
acid-injured rats was found to precede the associated
increased proliferation in renal tubular cells. In this re-
gard, a recent study has demonstrated that both HGF
and its c-met receptor gene expression show a similar
response pattern in this rat model of acute renal injury
[34]. However, opposite to the increased PTHrP immu-
nostaining found herein, a decrease in HGF protein lev-
els was observed in the kidney of rats with folic acid
injury [34]. The results of this study indicate that the
renal increase of c-met, which appears to be modulated
by various cytokines, appears to be a mechanism partici-
pating in the process of renal regeneration in this model
[34]. Thus, the possibility exists that PTHrP interacts
with this and perhaps other growth factor receptors in
renal cells to modulate the renal regenerative response
induced by folic acid acute injury.
In the present study, a single dose (3 or 50 g/kg) of
exogenously administered PTHrP (1-36) shortly after
folic acid injection significantly increased the number of
mRNA as a constitutive control, using RT-PCR. (B) Changes in PTHrP
Fig. 10. Effect of folic acid on parathyroid hromone-related protein mRNA levels, corrected to those of GAPDH mRNA, in cells exposed
(PTHrP) and the PTH/PTHrP receptor mRNA in NRK 52E cells. Cells to folic acid. Results are mean  SEM of values obtained with total
were serum-depleted for 24 hours before the addition of 10 mmol/L RNA isolated and pooled from three different culture wells in three
folic acid for different time periods. (A) Autoradiograms showing the different cell cultures. *P  0.05 compared with control (100%). FA,
analysis of PTHrP and the PTH/PTHrP receptor mRNA and GAPDH folic acid.
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PCNA-stained tubular cells at 24 hours, following a peak vitro, which affects the growth of these cells. Our results
support the notion that PTHrP plays a role in the regen-of PTHrP in plasma. This new finding demonstrates that
PTHrP displays mitogenic features for renal tubular cells erative process following acute renal injury induced by
folic acid. These findings also lend support to the hypoth-in vivo. On the other hand, exogenous PTHrP had no
effect on the time frame for the recovery of renal func- esis that PTHrP up-regulation is a common event associ-
tion in these rats after folic acid injury. In fact, we found ated with renal injury and repair. In addition, our findings
that the decreased renal function did not correlate with suggest that the renin-angiotensin system could partici-
tubular cell growth in folic acid-injected rats, treated or pate in the mechanisms responsible for the altered renal
not with PTHrP (1-36). It is hypothesized that changes function in this model.
in the renal microvasculature associated with folic acid
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